Cure Without Morbidity: Minimizing Pyrrhic Victories in Hematologic Malignancies |
01/06/2020 - 12:00pm to 1:00pm |
Drugging the Undruggable: Anti-Ras Therapy |
12/23/2019 - 12:00pm to 1:00pm |
Linking Longevity Regulators and Stem Cells of the Immune System |
12/16/2019 - 12:00pm to 1:00pm |
Evaluating Care, Quality of Life, and Mental Health Outcomes in Adults with Sickle Cell Disease |
12/02/2019 - 12:00pm to 1:00pm |
Patient Preferences for Treatment Outcomes: Bringing the Patient Voice into Cancer Care Delivery and Research |
11/18/2019 - 12:00pm to 1:00pm |
Updates in Osteoporosis and Use of Osteoclast Inhibitors |
11/11/2019 - 12:00pm to 1:00pm |
Targeted Therapies in Advanced-Phase Myeloproliferative Neoplasms and Symptom Burden and Early Palliative Care in Adolescents and Young Adults (AYA) with Hematologic Malignancies |
11/04/2019 - 12:00pm to 1:00pm |
Pharmacogenomics in Oncology and Novel Candidate Immuno-regulatory Molecules in Dysfunctional Tumor Infiltrating Lymphocytes |
10/28/2019 - 12:00pm to 1:00pm |
The Progression from Clonal Hematopoiesis to Myeloid Malignancy: A Bench to Bedside Perspective |
10/21/2019 - 12:00pm to 1:00pm |
Connecting the Dots of Behavioral Economics and Medical Decision-Making: Exploring Ambiguity Aversion’s Relationship to Biosimilar Prescribing |
10/07/2019 - 12:00pm to 1:00pm |